Association of an IL-4 gene haplotype with Graves disease in children: Experimental study and meta-analysis

Human Immunology

Volumn 72, Issue 3, 2011, Pages 256-261

  Lee, Yann Jinn ^a,b   Huang, Chi Yu ^a,c   Ting, Wei Hsin ^a,c   Lee, Hung Chang ^a,b   Guo, Wen Ling ^a   Chen, Wei Fang ^a   Lin, Chiung Ling ^a   Liu, Hsin Fu ^a   Lin, Marie ^a   Lo, Fu Sung ^d  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^d CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Case control study; Child; Ethnic Chinese; Graves disease; Haplotype; IL 4 gene; Meta analysis

Indexed keywords

AUTOANTIBODY; INTERLEUKIN 4;

ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; GRAVES DISEASE; HAPLOTYPE; HUMAN; IL 4 GENE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS (TOPIC); PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; ALLELES; AUTOANTIBODIES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; GRAVES DISEASE; HAPLOTYPES; HUMANS; INFANT; INFANT, NEWBORN; INTERLEUKIN-4; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; THYROID GLAND;

EID: 79651475419     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.12.014     Document Type: Article

References (79)

1. Jaksic J., Dumic M., Filipovic B., Ille J., Cvijetic M., Gjuric G. Thyroid diseases in a school population with thyromegaly. Arch Dis Child 1994, 70:103-106.
2. Stenszky V., Kozma L., Balazs C., Rochlitz S., Bear J.C., Farid N.R. The genetics of Graves' disease: HLA and disease susceptibility. J Clin Endocrinol Metab 1985, 61:735-740.
3. Brix T.H., Kyvik K.O., Christensen K., Hegedus L. Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts. J Clin Endocrinol Metab 2001, 86:930-934.
4. Tomer Y., Davies T.F. Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr Rev 2003, 24:694-717.
5. DiGeorge A.M., LaFranchi S. Disorder of the thyroid gland. Nelson Textbook of Pediatrics 1996, 1587-1605. Saunders, Philadelphia. 15th ed. R.E. Behrman, R.M. Kliegman, A.M. Arvin (Eds.).
6. Li-Weber M., Krammer P.H. Regulation of IL4 gene expression by T cells and therapeutic perspectives. Nat Rev Immunol 2003, 3:534-543.
7. Yamada T., Komiya I., Miyahara Y., Komatsu M., Shima I., Inazawa T., et al. Effect of methimazole treatment for 2 years on circulating IL-4, IgE, TBII, and TSAb in patients with hyperthyroid Graves' disease. Endocr J 2006, 53:783-788.
8. Dogan R.N., Vasu C., Holterman M.J., Prabhakar B.S. Absence of IL-4, and not suppression of the Th2 response, prevents development of experimental autoimmune Graves' disease. J Immunol 2003, 170:2195-2204.
9. Cantagrel A., Navaux F., Loubet-Lescoulié P., Nourhashemi F., Enault G., Abbal M., et al. Interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum 1999, 42:1093-1100.
10. Yu H.H., Liu P.H., Lin Y.C., Chen W.J., Lee J.H., Wang L.C., et al. Interleukin 4 and STAT6 gene polymorphisms are associated with systemic lupus erythematosus in Chinese patients. Lupus 2010, 19:1219-1228.
11. Hunt P.J., Marshall S.E., Weetman A.P., Bell J.I., Wass J.A., Welsh K.I. Cytokine gene polymorphisms in autoimmune thyroid disease. J Clin Endocrinol Metab 2000, 85:1984-1988.
12. Heward J.M., Nithiyananthan R., Allahabadia A., Gibson S., Franklyn J.A., Gough S.C. No association of an interleukin 4 gene promoter polymorphism with Graves' disease in the United Kingdom. J Clin Endocrinol Metab 2001, 86:3861-3863.
13. Tait K.F., Nithiyananthan R., Heward J.M., Barnett A.H., Franklyn J.A., Gough S.C. Polymorphisms of interleukin 4 receptor gene and interleukin 10 gene are not associated with Graves' disease in the UK. Autoimmunity 2004, 37:189-194.
14. Nakkuntod J., Wongsurawat T., Charoenwongse P., Snabboon T., Sridama V., Hirankarn N. No association between an interleukin 4 gene promoter (-589) polymorphism and Graves' disease in Thai patients. J Med Assoc Thai 2005, 87S2:S123-S128.
15. Yang Y., Lingling S., Ying J., Yushu L., Zhongyan S., Wei H., Weiping T. Association study between the IL4, IL13, IRF1 and UGRP1 genes in chromosomal 5q31 region and Chinese Graves' disease. J Hum Genet 2005, 50:574-582.
16. Egger M., Juni P., Bartlett C., Holenstein F., Sterne J. How important are comprehensive literature searches and the assessment of trial quality in systematic reviews?. Empirical study. Health Technol Assess 2003, 7:1-76.
17. Davies T.F., Larsen P.R. Thyrotoxicosis. Williams Textbook of Endocrinology 2003, 374-421. Saunders, St. Louis, MO. 10th ed. P.R. Larsen, H.M. Kronenberg, S. Melmed, K.S. Polonsky (Eds.).
18. Barlow A.B.T., Wheatchoft N., Watson P., Weetman A.P. Association of HLA-DQA1*0501 with Graves' disease in English Caucasian men and women. Clin Endocrinol 1996, 44:73-77.
19. Rosenwasser L.J., Klemm D.J., Dresback J.K., Inamura H., Mascali J.J., Klinnert M., et al. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy 1995, 25(Suppl 2):74-78.
20. Purcell S., Cherny S.S., Sham P.C. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003, 19:149-150.
21. Chang T.C., Wang C.Y., Lu C.P., Hong M.C., Wang P.D. Prevalence of goiter in school children in the Wan-Hwa district of Taipei. J Formos Med Assoc 1995, 94:193-196.
22. Wong G.W., Lam C.W., Kwok M.Y., Mak T.W., Ahuja A.T., Chow C.C., et al. Childhood goitre and urinary iodine excretion in Hong Kong. Eur J Pediatr 1998, 157:8-12.
23. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps Bioinformatics:21:263-5. http://www.broad.mit.edu/mpg/haploview.
24. Lee Y.J., Chen M.R., Chang W.C., Lo F.S., Huang F.Y. A freely available statistical program for testing association. MD Comput 1998, 15:327-330. (Freely available on request to yannlee@ms2.mmh.org.tw).
25. Ohashi J., Yamamoto S., Tsuchiya N., Hatta Y., Komata T., Matsushita M., et al. Comparison of statistical power between 2 * 2 allele frequency and allele positivity tables in case-control studies of complex disease genes. Ann Hum Genet 2001, 65:197-206.
26. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283:2008-2012.
27. Dorman J.S., LaPorte R.E., Store R.A., Trucco M. Worldwide differences in the incidence of type I diabetes are associated with amino acid variation at position 57 of the HLA-DQ beta chain. Proc Natl Acad Sci U S A 1990, 87:7370-7374.
28. Sterne J.A., Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol 2001, 54:1046-1055.
29. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
30. Cochran W.G. The combination of estimates from different experiments. Biometrics 1954, 10:101-129.
31. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
32. Takkouche B., Cadarso-Suárez C., Spiegelman D. Evaluation of old and new tests of heterogeneity in epidemiologic meta-analysis. Am J Epidemiol 1999, 150:206-215.
33. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558.
34. Gabriel S.B., Schaffner S.F., Nguyen H., Moore J.M., Roy J., Blumenstiel B., et al. The structure of haplotype blocks in the human genome. Science 2002, 296:2225-2229.
35. Shiau M.Y., Huang C.N., Yang T.P., Hwang Y.C., Tsai K.J., Chi C.J., et al. Cytokine promoter polymorphisms in Taiwanese patients with Graves' disease. Clin Biochem 2007, 40:213-217.
36. Chen R.H., Chang C.T., Wang T.Y., Chen C.C., Tsai C.H., Tsai F.J. Lack of association between interleukin-4 gene polymorphisms and autoimmune thyroid diseases amongst Taiwanese Chinese. Endocrine 2007, 32:170-174.
37. Nanba T., Watanabe M., Akamizu T., Iwatani Y. The -590CC genotype in the IL4 gene as a strong predictive factor for the development of hypothyroidism in Hashimoto disease. Clin Chem 2008, 54:621-623.
38. Khalilzadeh O., Anvari M., Momen-Heravi F., Esteghamati A., Rashidi A., Mahmoudi M., et al. Gene polymorphisms of interleukin-4, interleukin-10 and transforming growth factor-beta in Graves' disease. Clin Exp Med 2010, 10:123-128.
39. Zhu W., Liu N., Zhao Y., Jia H., Cui B., Ning G. Association analysis of polymorphisms in IL-3, IL-4, IL-5, IL-9, and IL-13 with Graves' disease. J Endocrinol Invest 2010, [Epub].
40. Drysdale C.M., McGraw D.W., Stack C.B., Stephens J.C., Judson R.S., Nandabalan K., et al. Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci U S A 2000, 97:10483-10488.
41. Fallin D., Cohen A., Essioux L., Chumakov I., Blumenfeld M., Cohen D., et al. Genetic analysis of case/control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer's disease. Genome Res 2001, 11:143-151.
42. Zaykin D.V., Westfall P.H., Young S.S., Karnoub M.A., Wagner M.J., Ehm M.G. Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 2002, 53:79-91.
43. A haplotype map of the human genome. Nature 2005, 437:1299-1320. The International HapMap Consortium.
44. Joosten P.H., Toepoel M., Mariman E.C., Van Zoelen E.J. Promoter haplotype combinations of the platelet-derived growth factor alpha-receptor gene predispose to human neural tube defects. Nat Genet 2001, 27:215-217.
45. Cowles C.R., Hirschhorn J.N., Altshuler D., Lander E.S. Detection of regulatory variation in mouse genes. Nat Genet 2002, 32:432-437.
46. Holla L.I., Fassmann A., Augustin P., Halabala T., Znojil V., Vanek J. The association of interleukin-4 haplotypes with chronic periodontitis in a Czech population. J Periodontol 2008, 79:1927-1933.
47. Kruglyak L. The use of a genetic map of biallelic markers in linkage studies. Nat Genet 1997, 17:21-24.
48. Todd J.A., Mijovic C., Fletcher J., Jenkins D., Bradwell A.L., Barnett A.H. Identification of susceptibility loci for insulin-dependent diabetes mellitus by trans-racial gene mapping. Nature 1989, 338:587-589.
49. Farrall M., Keavney B., McKenzie C., Delépine M., Matsuda F., Lathrop G.M. Fine-mapping of an ancestral recombination breakpoint in DCP1. Nat Genet 1999, 23:270-271.
50. Kabesch M., Tzotcheva I., Carr D., Hofler C., Weiland S.K., Fritzsch C., et al. A complete screening of the IL4 gene: novel polymorphisms and their association with asthma and IgE in childhood. J Allergy Clin Immunol 2003, 112:893-898.
51. Cardon L.R., Bell J.I. Association study designs for complex diseases. Nat Rev Genet 2001, 2:91-99.
52. Hirschhorn J.N., Altshuler D. Once and again-issues surrounding replication in genetic association studies. J Clin Endocrinol Metab 2002, 87:4438-4441.
53. Ioannidis J.P., Trikalinos T.A., Ntzani E.E., Contopoulos-Ioannidis D.G. Genetic associations in large versus small studies: an empirical assessment. Lancet 2003, 361:567-571.
54. Ioannidis J.P., Ntzani E.E., Trikalinos T.A., Contopoulos-Ioannidis D.G. Replication validity of genetic association studies. Nat Genet 2001, 29:306-309.
55. Attia J., Thakkinstian A., D'Este C. Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J Clin Epidemiol 2003, 56:297-303.
56. Thompson S.G., Pocock S.J. Can meta-analyses be trusted?. Lancet 1991, 338:1127-1130.
57. Fleiss J.L., Gross A.J. Meta-analysis in epidemiology, with special reference to studies of the association between exposure to environmental tobacco smoke and lung cancer: a critique. J Clin Epidemiol 1991, 44:127-139.
58. Olkin I. Diagnostic statistical procedures in medical meta-analyses. Stat Med 1999, 18:2331-2341.
59. Kruglyak L., Nickerson D.A. Variation is the spice of life. Nat Genet 2001, 27:234-236.
60. Lee H.H., Lee Y.J., Chan P., Lin C.Y. Use of PCR-based amplification analysis as a substitute for the Southern blot method for CYP21 deletion detection in congenital adrenal hyperplasia. Clin Chem 2004, 50:1074-1076.
61. Sherry S.T., Ward M., Sirotkin K. Use of molecular variation in the NCBI dbSNP database. Hum Mutat 2000, 15:68-75.
62. Ardlie K.G., Kruglyak L., Seielstad M. Patterns of linkage disequilibrium in the human genome. Nat Rev Genet 2002, 3:299-309.
63. Little J. Reporting and review of human genome epidemiology studies. Human Genome Epidemiology: a Scientific Foundation for Using Genetic Information to Improve Health and Prevent Disease 2004, 168-194. Oxford University Press, Oxford. M.J. Khoury, J. Little, W. Burke (Eds.).
64. Nakashima H., Miyake K., Inoue Y., Shimizu S., Akahoshi M., Tanaka Y., et al. Association between IL-4 genotype and IL-4 production in the Japanese population. Genes Immun 2002, 3:107-109.
65. Tomer Y., Davies T.F. The genetics of familial and non-familial hyperthyroid Graves' disease. Graves' Disease: Pathogenesis and Treatment 2000, 19-42. Kluwer Academic, Boston. B. Rapoport, S.M. McLachlan (Eds.).
66. Morton N.E., Collins A. Tests and estimates of allelic association in complex inheritance. Proc Natl Acad Sci U S A 1998, 95:11389-11393.
67. Marron M.P., Raffel L.J., Garchon H.J., Jacob C.O., Serrano-Rios M., Martinez Larrad M.T., et al. Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum Mol Genet 1997, 6:1275-1282.
68. Schaid D.J. Transmission disequilibrium, family controls, and great expectations. Am J Hum Genet 1998, 63:935-941.
69. Pericak-Vance M.A. Basic concepts in linkage analysis. Approaches to Gene Mapping in Complex Human Diseases 1998, 77-92. Wiley-Liss, New York. J.L. Haines, M.A. Pericak-Vance (Eds.).
70. Haines J.L. Affected relative pair analysis. Approaches to Gene Mapping in Complex Human Diseases 1998, 305-321. Wiley-Liss, New York. J.L. Haines, M.A. Pericak-Vance (Eds.).
71. Bugawan T.L., Mirel D.B., Valdes A.M., Panelo A., Pozzilli P., Erlich H.A. Association and interaction of the IL4R, IL4, and IL13 Loci with type 1 diabetes among Filipinos. Am J Hum Genet 2003, 72:1505-1514.
72. Maier L.M., Chapman J., Howson J.M., Clayton D.G., Pask R., Strachan D.P., et al. No evidence of association or interaction between the IL4RA, IL4, and IL13 genes in type 1 diabetes. Am J Hum Genet 2005, 76:517-521.
73. Lonjou C., Zhang W., Collins A., Tapper W.J., Elahi E., Maniatis N., et al. Linkage disequilibrium in human populations. Proc Natl Acad Sci U S A 2003, 100:6069-6074.
74. Barbujani G., Magagni A., Minch E., Cavalli-Sforza L.L. An apportionment of human DNA diversity. Proc Natl Acad Sci U S A 1997, 94:4516-4519.
75. Rosenberg N.A., Pritchard J.K., Weber J.L., Cann H.M., Kidd K.K., Zhivotovsky L.A., et al. Genetic structure of human populations. Science 2002, 298:2381-2385.
76. Kimura M. Evolutionary rate at the molecular level. Nature 1968, 217:624-626.
77. Jorde L.B., Rogers A.R., Bamshad M., Watkins W.S., Krakowiak P., Sung S., et al. Microsatellite diversity and the demographic history of modern humans. Proc Natl Acad Sci U S A 1997, 94:3100-3103.
78. Integrating ethics and science in the International HapMap Project. Nat Rev Genet 2004, 5:467-475. The International HapMap Consortium.
79. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447:661-678. Wellcome Trust Case Control Consortium.